MTSR
Metsera Inc

745
Mkt Cap
$7.43B
Volume
27.91M
52W High
$83.86
52W Low
$12.30
PE Ratio
-23.55
MTSR Fundamentals
Price
$70.50
Prev Close
$70.75
Open
$70.74
50D MA
$56.89
Beta
1.60
Avg. Volume
1.88M
EPS (Annual)
-$1.99
P/B
21.99
Rev/Employee
$0.00
Loading...
Loading...
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
81

Frequently Asked Questions

What is Market Cap of Metsera Inc.?
What is the 52-week high for Metsera Inc.?
What is the 52-week low for Metsera Inc.?
What is Metsera Inc. stock price today?
What was Metsera Inc. stock price yesterday?
What is the PE ratio of Metsera Inc.?
What is the Price-to-Book ratio of Metsera Inc.?
What is the 50-day moving average of Metsera Inc.?
How many employess does Metsera Inc. has?

Latest MTSR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.